Back
Speaker illustration

undefined undefined undefined

Presentations

Preclinical proof-of-concept study: antisense-mediated knockdown of CALM as a therapeutic strategy for calmodulinopathy

Event: ESC Congress 2020

Topic: Arrhythmias

Session: New Insights into Arrhythmogenesis

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources